Multiplexed Microarray Detection of Pluripotency Related Proteins

Information

  • Research Project
  • 7610858
  • ApplicationId
    7610858
  • Core Project Number
    R43GM086934
  • Full Project Number
    1R43GM086934-01
  • Serial Number
    86934
  • FOA Number
    PA-08-050
  • Sub Project Id
  • Project Start Date
    2/1/2009 - 15 years ago
  • Project End Date
    4/30/2010 - 14 years ago
  • Program Officer Name
    PORTNOY, MATTHEW
  • Budget Start Date
    2/1/2009 - 15 years ago
  • Budget End Date
    4/30/2010 - 14 years ago
  • Fiscal Year
    2009
  • Support Year
    1
  • Suffix
  • Award Notice Date
    1/26/2009 - 15 years ago

Multiplexed Microarray Detection of Pluripotency Related Proteins

DESCRIPTION (provided by applicant): Primorigen Biosciences will use SBIR funds to develop a frameless, multiplexed, microarray screening system for rapid identification and characterization of antibody matched pairs with appropriate affinity and specificity for human proteins central to pluripotency and multipotency. This system produces improved assay content and dramatically reduces the time and cost of multiplexed microarray development. The core of this new system is Primorigen's novel frameless microarray device that allows multiplexed analysis of 96 (or 384) samples against several binding targets directly on a flat array surface. As a result, dozens of proteins in hundreds of samples can be detected with high precision to generate thousands of data points per experiment, increasing speed of screening. While the new system can be adapted for detection of any protein, this Phase I SBIR project will focus on characterizing assay content for detecting eight human cell markers of pluripotency and multipotency and validating them in a multiplexed array format. Phase II will a) complete additional microarrays of up to 15-20 multiplex assays, b) further develop automated methods to increase assay throughput, c) apply this system to pathway analysis involved in determining or maintaining cell potency and d) expand assay development to endoderm, mesoderm, and ectoderm markers. PUBLIC HEALTH RELEVANCE: Proteins facilitate many of the cell's most basic functions and thousands of new protein sequences and post-translational variants have been identified in the past few years. This protein jackpot has hastened the drive to understand protein-based regulation, but researchers require better biophysical methods to quantitatively detect protein markers. Primorigen's inexpensive, miniaturized, multiplexed, high throughput assays proposed for SBIR support will address this need, generating thousands of protein detection data points per experiment. At the same time, the project will provide new antibody and protein content for assays to detect human proteins central to pluripotency and multipotency.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    184593
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:184593\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PRIMORIGEN BIOSCIENCES, INC.
  • Organization Department
  • Organization DUNS
    782932177
  • Organization City
    MADISON
  • Organization State
    WI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    53719
  • Organization District
    UNITED STATES